[ 1 ] Harvey AL, Edrada-Ebel R, Quinn RJ. The re-emergence of natural products for drug discovery in the genomics era. Nat Rev Drug Discov 2015;14(2):111–29. link1

[ 2 ] Zhang A, Sun H, Wang X. Recent advances in natural products from plants for treatment of liver diseases. Eur J Med Chem 2013;63:570–7. link1

[ 3 ] Hu J, Pang WS, Han J, Zhang K, Zhang JZ, Chen LD. Gualou Guizhi decoction reverses brain damage with cerebral ischemic stroke, multi-component directed multi-target to screen calcium-overload inhibitors using combination of molecular docking and protein-protein docking. J Enzyme Inhib Med Chem 2018;33(1):115–25. link1

[ 4 ] Chen L, Wang X, Liu Y, Di X. Dual-target screening of bioactive components from traditional Chinese medicines by hollow fiber-based ligand fishing combined with liquid chromatography-mass spectrometry. J Pharm Biomed Anal 2017;143:269–76. link1

[ 5 ] Cui L, Cai Y, Cheng W, Liu G, Zhao J, Cao H, et al. A novel, multi-target natural drug candidate, matrine, improves cognitive deficits in Alzheimer’s disease transgenic mice by inhibiting Ab aggregation and blocking the RAGE/Ab axis. Mol Neurobiol 2017;54(3):1939–52. link1

[ 6 ] Cao H, Zhang A, Zhang H, Sun H, Wang X. The application of metabolomics in traditional Chinese medicine opens up a dialogue between Chinese and Western medicine. Phytother Res 2015;29(2):159–66. link1

[ 7 ] Zhang Y, Liu Y, Li Y, Zhao X, Zhuo L, Zhou A, et al. Hierarchical and complex system entropy clustering analysis based validation for traditional Chinese medicine syndrome patterns of chronic atrophic gastritis. J Altern Complement Med. Epub 2018 Mar 22. link1

[ 8 ] Wang X, Zhang A, Sun H. Future perspectives of Chinese medical formulae: chinmedomics as an effector. OMICS 2012;16(7–8):414–21. link1

[ 9 ] Zhang AH, Sun H, Yan GL, Wang P, Han Y, Wang XJ. Chinmedomics: a new strategy for research of traditional Chinese medicine. China J Chin Mater Med 2015;40(4):569–76. Chinese. link1

[10] Liu Q, Zhao HW, Zhang AH, Sun H, Zhao XH, Nan Y, et al. Chinmedomics strategy to discover effective constituents and elucidate action mechanism of Nanshi capsule against kidney-yang deficiency syndrome. China J Chin Mater Med 2016;41(15):2901–14. Chinese. link1

[11] Wang X, Zhang A, Sun H, Wang P. Systems biology technologies enable personalized traditional Chinese medicine: a systematic review. Am J Chin Med 2012;40(6):1109–22. link1

[12] Zhang A, Sun H, Yan G, Cheng W, Wang X. Systems biology approach opens door to essence of acupuncture. Complement Ther Med 2013;21(3):253–9. link1

[13] Zhang ND, Han T, Huang BK, Rahman K, Xu HT, Jiang YP, et al. Traditional Chinese medicine formulas for the treatment of osteoporosis: implication for antiosteoporotic drug discovery. J Ethnopharmacol 2016;189:61–80. link1

[14] Chen M, Yang F, Yang X, Lai X, Gao Y. Systematic understanding of mechanisms of a Chinese herbal formula in treatment of metabolic syndrome by an integrated pharmacology approach. Int J Mol Sci 2016;17(12):E2114. link1

[15] Xiang Z, Sun H, Cai X, Chen D, Zheng X. The study on the material basis and the mechanism for anti-renal interstitial fibrosis efficacy of rhubarb through integration of metabonomics and network pharmacology. Mol Biosyst 2015;11(4):1067–78. link1

[16] Li XN, Zhang A, Sun H, Song Y, Zou D, Wang X. Rapid discovery of absorbed constituents and metabolites in rat plasma after the oral administration of Zi Shen Wan using high-throughput UHPLC-MS with a multivariate analysis approach. J Sep Sci 2016;39(24):4700–11. link1

[17] Chu H, Zhang A, Han Y, Lu S, Kong L, Han J, et al. Metabolomics approach to explore the effects of Kai-Xin-San on Alzheimer’s disease using UPLC/ESI-QTOF mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2016;1015–1016:50–61. link1

[18] Sun H, Chen X, Zhang A, Sakurai T, Jiang J, Wang X. Chromatographic fingerprinting analysis of Zhizhu Wan preparation by high-performance liquid chromatography coupled with photodiode array detector. Pharmacogn Mag 2014;10(40):470–6. link1

[19] Zhang A, Zou D, Yan G, Tan Y, Sun H, Wang X. Identification and characterization of the chemical constituents of Simiao Wan by ultra high performance liquid chromatography with mass spectrometry coupled to an automated multiple data processing method. J Sep Sci 2014;37(14):1742–7. link1

[20] Wang XJ. Progress and future developing of the serum pharmacochemistry of traditional Chinese medicine. China J Chin Mater Med 2006;31(10):789–92, 835. Chinese. link1

[21] Wang X, Lv H, Sun H, Liu L, Yang B, Sun W, et al. Metabolic urinary profiling of alcohol hepatotoxicity and intervention effects of Yin Chen Hao Tang in rats using ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry. J Pharm Biomed Anal 2008;48 (4):1161–8. link1

[22] Zhang A, Yan G, Zhou X, Wang Y, Han Y, Guan Y, et al. High resolution metabolomics technology reveals widespread pathway changes of alcoholic liver disease. Mol Biosyst 2016;12(1):262–73. link1

[23] Wang X, Zhang A, Zhou X, Liu Q, Nan Y, Guan Y, et al. An integrated chinmedomics strategy for discovery of effective constituents from traditional herbal medicine. Sci Rep 2016;6:18997. link1

[24] Zhang A, Sun H, Wang Z, Sun W, Wang P, Wang X. Metabolomics: towards understanding traditional Chinese medicine. Planta Med 2010;76 (17):2026–35. link1

[25] Yu J, Kong L, Zhang A, Han Y, Liu Z, Sun H, et al. High-throughput metabolomics for discovering potential metabolite biomarkers and metabolic mechanism from the APPswe/PS1dE9 transgenic model of Alzheimer’s disease. J Proteome Res 2017;16(9):3219–28. link1

[26] Sun H, Zhang A, Wang X. Potential role of metabolomic approaches for Chinese medicine syndromes and herbal medicine. Phytother Res 2012;26 (10):1466–71. link1

[27] Wang X, Sun H, Zhang A, Sun W, Wang P, Wang Z. Potential role of metabolomics approaches in the area of traditional Chinese medicine: as pillars of the bridge between Chinese and Western medicine. J Pharm Biomed Anal 2011;55(5):859–68. link1

[28] Wang X, Zhang A, Han Y, Wang P, Sun H, Song G, et al. Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease. Mol Cell Proteomics 2012;11(8):370–80. link1

[29] Sun H, Zhang A, Yan G, Piao C, Li W, Sun C, et al. Metabolomic analysis of key regulatory metabolites in hepatitis C virus-infected tree shrews. Mol Cell Proteomics 2013;12(3):710–9. link1

[30] Liu Q, Zhang A, Wang L, Yan G, Zhao H, Sun H, et al. High-throughput chinmedomics-based prediction of effective components and targets from herbal medicine AS1350. Sci Rep 2016;6:38437. link1

[31] Yan GL, Sun H, Zhang AH, Han Y, Wang P, Wu XH, et al. Progress of serum pharmacochemistry of traditional Chinese medicine and further development of its theory and method. China J Chin Mater Med 2015;40(17):3406–12. Chinese. link1

[32] Zhao W, Shang Z, Li Q, Huang M, He W, Wang Z, et al. Rapid screening and identification of daidzein metabolites in rats based on UHPLC-LTQ-Orbitrap mass spectrometry coupled with data-mining technologies. Molecules 2018;23(1):E151. link1

[33] Yan GL, Zhang AH, Sun H, Han Y, Shi H, Zhou Y, et al. An effective method for determining the ingredients of Shuanghuanglian formula in blood samples using high-resolution LC–MS coupled with background subtraction and a multiple data processing approach. J Sep Sci 2013;36(19):3191–9. link1

[34] Cao H, Zhang A, Zhang FM, Wang QQ, Zhang H, Song YH, et al. Ultraperformance liquid chromatography tandem mass spectrometry combined with automated MetaboLynx analysis approach to screen the bioactive components and their metabolites in Wen-Xin-Formula. Biomed Chromatogr 2014;28(12):1774–81. link1

[35] Sun H, Dong W, Zhang A, Wang W, Wang X. Pharmacokinetics study of multiple components absorbed in rat plasma after oral administration of Stemonae radix using ultra-performance liquid–chromatography/mass spectrometry with automated MetaboLynx software analysis. J Sep Sci 2012;35(24):3477–85. link1

[36] Wang X, Zhang A, Sun H, editors. Chinmedomics: the integration of serum pharmacochemistry and metabolomics to elucidate the scientific value of traditional Chinese medicine. Cambridge: Academic Press; 2015.

[37] Wang X, Zhang A, Sun H, Yan G. Chinmedomics: newer theory and application.Chin Herb Med 2016;8(4):299–307. link1

[38] Wang X, Zhang A, Sun H, Yan G. Origin of chinmedomics. In: Chinmedomics: the integration of serum pharmacochemistry and metabolomics to elucidate the scientific value of traditional Chinese medicine. Cambridge: Academic Press; 2015. p. 1–15. link1

[39] Wang X, Zhang A, Sun H, Han Y. Methods and protocols of chinmedomics. In: Wang X, Zhang A, Sun H, editors. Chinmedomics: the integration of serum pharmacochemistry and metabolomics to elucidate the scientific value of traditional Chinese medicine. Cambridge: Academic Press; 2015. p. 17–27. link1

[40] Chu H, Zhang A, Han Y, Wang X. Metabolomics and its potential in drug discovery and development from TCM. World J Tradit Chin Med 2015;1 (4):26–32. link1

[41] Wang X, Zhang A, Sun H, Han Y, Yan G. Discovery and development of innovative drug from traditional medicine by integrated chinmedomics strategies in the post-genomic era. TrAC Trends Anal Chem 2016;76:86–94. link1

[42] Dong H, Yan GL, Han Y, Sun H, Zhang AH, Li XN, et al. UPLC-Q-TOF/MS-based metabolomic studies on the toxicity mechanisms of traditional Chinese medicine Chuanwu and the detoxification mechanisms of Gancao, Baishao, and Ganjiang. Chin J Nat Med 2015;13(9):687–98. link1

[43] Zhao Q, Zhang A, Zong W, An N, Zhang H, Luan Y, et al. Chemometrics strategy coupled with high resolution mass spectrometry for analyzing and interpreting comprehensive metabolomic characterization of hyperlipemia. RSC Adv 2016;6(113):112534–43. link1

[44] Wang X, Zhang A, Yan G, Han Y, Sun H. UHPLC-MS for the analytical characterization of traditional Chinese medicines. TrAC Trends Anal Chem 2014;63:180–7. link1

[45] Zhang T, Zhang A, Qiu S, Yang S, Wang X. Current trends and innovations in bio-analytical techniques of metabolomics. Crit Rev Anal Chem 2016;46 (4):342–51. link1

[46] Ren J, Zhang A, Kong L, Wang X. Advances in mass spectrometry-based metabolomics for investigation of metabolites. RSC Adv 2018;8(40):22335–50. link1

[47] Han Y, Zhang AH, Zhang YZ, Sun H, Meng XC, Wang XJ. Chemical metabolomics for investigating the protective effectiveness of Acanthopanax senticosus Harms leaf against acute promyelocytic leukemia. RSC Adv 2018;8(22):11983–90. link1

[48] XieJ,ZhangA,SunH,YanG,WangX.Recentadvancesandeffectivestrategiesin the discovery and applications of natural products. RSC Adv 2018;8(2):812–24. link1

[49] Song Q, Zhang AH, Yan GL, Liu L, Wang XJ. Technological advances in current metabolomics and its application in tradition Chinese medicine. RSC Adv 2017;7(84):53516–24. link1

[50] Sun H, Liu J, Zhang A, Zhang Y, Meng X, Han Y, et al. Characterization of the multiple components of Acanthopanax senticosus stem by ultra high performance liquid chromatography with quadrupole time-of-flight tandem mass spectrometry. J Sep Sci 2016;39(3):496–502. link1

[51] Liu C, Zhang A, Yan GL, Shi H, Sun H, Han Y, et al. High-throughput ultra high performance liquid chromatography coupled to quadrupole time-of-flight mass spectrometry method for the rapid analysis and characterization of multiple constituents of Radix Polygalae. J Sep Sci 2017;40(3):663–70. link1

[52] Zhang A, Sun H, Yan G, Wang P, Wang X. Mass spectrometry-based metabolomics: applications to biomarker and metabolic pathway research. Biomed Chromatogr 2016;30(1):7–12. link1

[53] Zhang A, Sun H, Yan G, Wang P, Wang X. Metabolomics for biomarker discovery: moving to the clinic. Biomed Res Int 2015;2015:354671. link1

[54] Li X, Sun H, Zhang A, Liu Z, Zou D, Song Y, et al. High-throughput LC–MS method for the rapid characterization of multiple chemical constituents and metabolites of Da-Bu-Yin-Wan. J Sep Sci 2017;40(21):4102–12. link1

[55] Zhang A, Fang H, Wang Y, Yan G, Sun H, Zhou X, et al. Discovery and verification of the potential targets from bioactive molecules by network pharmacology-based target prediction combined with high-throughput metabolomics. RSC Adv 2017;7(81):51069–78. link1

[56] Zhao Q, Zhang A, Zong W, An N, Zhang H, Luan Y, et al. Exploring potential biomarkers and determining the metabolic mechanism of type 2 diabetes mellitus using liquid chromatography coupled to high-resolution mass spectrometry. RSC Adv 2017;7(70):44186–98. link1

[57] Zhang A, Sun H, Wang X. Emerging role and recent applications of metabolomics biomarkers in obesity diseases research. RSC Adv 2017;7 (25):14966–73. link1

[58] Xie J, Zhang A, Wang X. Metabolomic applications in hepatocellular carcinoma: toward the exploration of therapeutics and diagnosis through small molecules. RSC Adv 2017;7(28):17217–26. link1

[59] Zhang A, Sun H, Yan G, Wang X. Recent developments and emerging trends of mass spectrometry for herbal ingredients analysis. TrAC Trends Anal Chem 2017;94:70–6. link1

[60] Liu XY, Zhang AH, Fang H, Li MX, Song Q, Su J, et al. Serum metabolomics strategy for understanding the therapeutic effects of Yin-Chen-Hao-Tang against Yanghuang syndrome. RSC Adv 2018;8(14):7403–13. link1

[61] Fang H, Zhang A, Yu J, Wang L, Liu C, Zhou X, et al. Insight into the metabolic mechanism of scoparone on biomarkers for inhibiting Yanghuang syndrome. Sci Rep 2016;6:37519. link1

[62] Zhou XH, Zhang AH, Wang L, Tan YL, Guan Y, Han Y, et al. Novel chinmedomics strategy for discovering effective constituents from ShenQiWan acting on ShenYangXu syndrome. Chin J Nat Med 2016;14(8):561–81. link1

[63] Zhang A, Liu Q, Zhao H, Zhou X, Sun H, Nan Y, et al. Phenotypic characterization of nanshi oral liquid alters metabolic signatures during disease prevention. Sci Rep 2016;6:19333. link1

[64] Wang P, Sun H, Lv H, Sun W, Yuan Y, Han Y, et al. Thyroxine and reserpine-induced changes in metabolic profiles of rat urine and the therapeutic effect of Liu Wei Di Huang Wan detected by UPLC-HDMS. J Pharm Biomed Anal 2010;53(3):631–45. link1

[65] Wang X, Wang Q, Zhang A, Zhang F, Zhang H, Sun H, et al. Metabolomics study of intervention effects of Wen-Xin-Formula using ultra high-performance liquid chromatography/mass spectrometry coupled with pattern recognition approach. J Pharm Biomed Anal 2013;74:22–30. link1

[66] Sun H, Yang L, Li MX, Fang H, Zhang AH, Song Q, et al. UPLC-G2Si-HDMS untargeted metabolomics for identification of metabolic targets of Yin-Chen-Hao-Tang used as a therapeutic agent of dampness-heat jaundice syndrome. J Chromatogr B Analyt Technol Biomed Life Sci 2018;1081–1082:41–50. link1

[67] Wang X, Yang B, Zhang A, Sun H, Yan G. Potential drug targets on insomnia and intervention effects of Jujuboside A through metabolic pathway analysis as revealed by UPLC/ESI-SYNAPT-HDMS coupled with pattern recognition approach. J Proteomics 2012;75(4):1411–27. link1

[68] Zhang A, Sun H, Han Y, Yuan Y, Wang P, Song G, et al. Exploratory urinary metabolic biomarkers and pathways using UPLC-Q-TOF-HDMS coupled with pattern recognition approach. Analyst 2012;137(18):4200–8. link1

[69] Zhang A, Sun H, Qiu S, Wang X. Advancing drug discovery and development from active constituents of Yinchenhao Tang, a famous traditional Chinese medicine formula. Evid Based Complement Alternat Med 2013;2013:257909. link1

[70] Wang P, Lv H, Zhang A, Sun H, Yan G, Han Y, et al. Improved ultra-performance liquid chromatography with electrospray ionization quadrupole-time-of-flight high-definition mass spectrometry method for the rapid analysis of the chemical constituents of a typical medical formula: Liuwei Dihuang Wan. J Sep Sci 2013;36(21–22):3511–6. link1

[71] Wang H, Sun H, Zhang A, Li Y, Wang L, Shi H, et al. Rapid identification and comparative analysis of the chemical constituents and metabolites of Phellodendri amurensis cortex and Zhibaidihuang pill by ultra-performance liquid chromatography with quadrupole TOF-MS. J Sep Sci 2013;36 (24):3874–82. link1

[72] Nan Y, Zhou X, Liu Q, Zhang A, Guan Y, Lin S, et al. Serum metabolomics strategy for understanding pharmacological effects of ShenQi pill acting on kidney yang deficiency syndrome. J Chromatogr B Analyt Technol Biomed Life Sci 2016;1026:217–26. link1

[73] Yang B, Zhang A, Sun H, Dong W, Yan G, Li T, et al. Metabolomic study of insomnia and intervention effects of Suanzaoren decoction using ultra-performance liquid–chromatography/electrospray-ionization synapt high-definition mass spectrometry. J Pharm Biomed Anal 2012;58:113–24. link1

[74] Zhang AH, Yu JB, Sun H, Kong L, Wang XQ, Zhang QY, et al. Identifying quality-markers from Shengmai San protects against transgenic mouse model of Alzheimer’s disease using chinmedomics approach. Phytomedicine 2018;45:84–92. link1

[75] Lu S, Han Y, Chu H, Kong L, Zhang A, Yan G, et al. Characterizing serum metabolic alterations of Alzheimer’s disease and intervention of Shengmai-San by ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry. Food Funct 2017;8(4):1660–71. link1

[76] Han Y, Wu F, Zhang A, SunH Wei W, Wang X, et al. Characterization of multiple constituents in rat plasma after oral administration of Shengmai San using ultra-performance liquid chromatography coupled with electrospray ionization/quadrupole-time-of-flight high-definition mass spectrometry. Anal Methods 2015;7(3):830–7. link1

[77] Wang X, Zhang S, Zhang A, Yan G, Wu X, Han Y, et al. Metabolomics study of type 2 diabetes and therapeutic effects of Tianqijiangtang-capsule using ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry. Anal Methods 2013;5(9):2218–26. link1

[78] Yan GL, Zhang AH, Sun H, Han Y, Shi H, Zhou Y, et al. An effective method for determining the ingredients of Shuanghuanglian formula in blood samples using high-resolution LC–MS coupled with background subtraction and a multiple data processing approach. J Sep Sci 2013;36 (19):3191–9. link1

[79] Gao HL, Zhang AH, Yu JB, Sun H, Kong L, Wang XQ, et al. High-throughput lipidomics characterize key lipid molecules as potential therapeutic targets of Kaixinsan protects against Alzheimer’s disease in APP/PS1 transgenic mice. J Chromatogr B Analyt Technol Biomed Life Sci 2018;1092:286–95. link1

[80] Wu XH, Zhao C, Zhang AH, Zhang JQ, Wang X, Sun XL, et al. High-throughput metabolomics used to identify potential therapeutic targets of Guizhi Fuling Wan against endometriosis of cold coagulation and blood stasis. RSC Adv 2018;8(34):19238–50. link1

[81] Sun H, Zhang A, Yang L, Li M, Fang H, Xie J, et al. High-throughput chinmedomics strategy for discovering the quality-markers and potential targets for Yinchenhao decoction. Phytomedicine. In press. http://doi.org/10.1016/j.phymed.2018.04.015.

[82] Zhang A, Sun H, Wang X. Mass spectrometry-driven drug discovery for development of herbal medicine. Mass Spectrom Rev 2018;37(3):307–20. link1

[83] Li XN, Zhang A, Wang M, Sun H, Liu Z, Qiu S, et al. Screening the active compounds of Phellodendri Amurensis cortex for treating prostate cancer by high-throughput chinmedomics. Sci Rep 2017;7:46234. link1

[84] Jiang Z, Yang J, Wang Y. Discrimination and identification of Q-markers based on ‘Spider-web’ mode for quality control of traditional Chinese medicine. Phytomedicine. Epub 2017 Dec 28.

[85] Yang W, Zhang Y, Wu W, Huang L, Guo D, Liu C. Approaches to establish Q-markers for the quality standards of traditional Chinese medicines. Acta Pharm Sin B 2017;7(4):439–46. link1

[86] Wang X, Zhang A, Kong L, Yu J, Gao H, Liu Z, et al. Rapid discovery of quality-markers from Kaixin San using chinmedomics analysis approach. Phytomedicine. In press. http://doi.org/10.1016/j.phymed.2017.12.014.

[87] Zhang A, Sun H, Wang X. Potentiating therapeutic effects by enhancing synergism based on active constituents from traditional medicine. Phytother Res 2014;28(4):526–33. link1

[88] Liu CX. Chinmedomics builds a bridge from traditional to modern research of traditional Chinese medicine. Chin Herb Med 2016;8(4):297–8. link1

[89] Sang XX, Wang ZX, Liu SY, Wang RL. Relationship between traditional Chinese medicine (TCM) constitution and TCM syndrome in the diagnosis and treatment of chronic diseases. Chin Med Sci J 2018;33(2):114–9. link1

[90] Li Q, Zhang A, Sun H, Wang X. Pharmacokinetics applications of traditional Chinese medicines. World J Tradit Chin Med 2016;2(1):42–7. link1

[91] Ma L, Wang B, Long Y, Li H. Effect of traditional Chinese medicine combined with Western therapy on primary hepatic carcinoma: a systematic review with meta-analysis. Front Med 2017;11(2):191–202. link1